Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations
{{output}}
Patients with NSCLC in East Asia, including Japan, frequently contain EGFR mutations. In 2018, we published the latest full clinical practice guidelines on the basis of those provided by the Japanese Lung Cancer Society Guidelines Committee. The purpose of thi... ...
